-
Cutting Cancer’s EngineRenewed interest in research about metabolism, the process cells use to fuel their growth, could lead to new types of cancer treatments.
by Stephen Ornes
-
Missing the MarkOnly one-third of new cancer therapies or drug combinations tested in phase III clinical trials prove to be better than the standard of care. Researchers explain why and how they are aiming to improve the odds.
by Sue Rochman
-
Healthy Habits
Going With the GrainA fiber-rich diet can reduce cancer risk.
by Alanna Kennedy-Gorman
-
Forward Look
Can Genetic Ancestry Help Explain Cancer Risk?Q&A with Rick Kittles, associate professor of medicine and epidemiology and biostatistics at the University of Illinois College of Medicine in Chicago.
by Stephen Ornes
-
Forward Look
The Cancer Genome AtlasLarge-scale genomics effort could lead to new strategies for tackling cancer.
by Alexandra Goho
-
Forward Look
Carrying a Heavy BurdenStudies find overweight kids and teens have higher adult cancer risk.
by Leslie Harris O'Hanlon
-
Forward Look
Guiding Patients From Screening Through TreatmentPatient navigators can play an important role in cancer care.
by Alanna Kennedy-Gorman
-
Forward Look
Vitamin E and Cancer RiskStudies send mixed signals on potential benefits and harmful effects of vitamin E.
by Mitzi Baker
-
Forward Look
Bridging the DistanceQ&A with medical oncologist Ana María López, medical director of the telemedicine program at the University of Arizona Cancer Center in Tucson.
by Sue Rochman
-
Forward Look
Treading Carefully With Medical ScansTo reduce your long-term cancer risk, make sure the tests are justified.
by Ingfei Chen
After caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
